Disseminated intravascular coagulation: diagnosis and treatment.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMC 2350519)

Published in BMJ on March 16, 1996

Authors

T Baglin1

Author Affiliations

1: Department of Haematology, Addenbrooke's NHS Trust, Cambridge.

Articles cited by this

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest (1987) 3.29

Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med (1980) 3.03

Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood (1990) 2.04

Disseminated intravascular coagulation (DIC): an approach. Am J Med (1972) 1.87

Effect on blood coagulation of massive intravascular haemolysis. Blood (1969) 1.61

Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem (1990) 1.59

Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood (1990) 1.57

Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med (1985) 1.38

Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest (1993) 1.35

Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. Thromb Haemost (1978) 1.30

Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost (1980) 1.26

Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood (1982) 1.23

Formation of human plasma kinin. N Engl J Med (1974) 1.21

Diagnosis of disseminated intravascular coagulation. Role of D-dimer. Am J Clin Pathol (1989) 1.01

Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes--a multicentre trial. Thromb Haemost (1983) 0.99

Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders. Arch Intern Med (1989) 0.97

Quantitation of reticulated platelets: methodology and clinical application. Br J Haematol (1995) 0.93

Beneficial effect of heparin in the management of patients with APL. Br J Haematol (1988) 0.84

Cysteine proteinase procoagulant from amnion-chorion. Blood (1985) 0.83

Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. JAMA (1987) 0.81

Treatment of disseminated intravascular coagulation and its prodromal stage with gabaxate mesilate (FOY): a multi-center trial. Acta Haematol (1993) 0.81

Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease. J Lab Clin Med (1993) 0.80

Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy. Blood Coagul Fibrinolysis (1995) 0.80